Eton Pharmaceuticals, Inc. stock is down -4.85% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 February’s closed higher than January.
Eton Pharmaceuticals, Inc. focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting from vasodilation in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!